Washington (AP) – President Donald Trump’s plan to change the pricing model for some medication is already exposed to violent criticism from the pharmaceutical industry before signing the executive regulation defined for Monday, which, if they are implemented, could reduce the costs of some drugs.
Trump has promised that his plan, which is covered by Medicare and administered in a doctor’s office, is likely to be administered at the lowest price of other countries that will significantly reduce drug costs.
“I will set up a most preferred national policy in which the United States pay the same price as the nation that pays the lowest price all over the world,” the Republican President scored on Sunday and promised to sign the order in the White House on Monday morning.
But the leading pharmaceutical lobby of the nation on Sunday returned it and described it as “bad business” for American patients. Drug makers have long argued that all threats to their profits could influence research that they could have to develop to develop modern medication.
“Importing foreign prices are reduced by Medicare billions of dollars without helping patients or improving their access to medication,” said Stephen J. Ubl, President and CEO of Phrma. “It endangers the hundreds of billions that are planning to invest our member companies in America and make us more in China for innovative medication.”
Trump’s so -called “most preferred nation” approach for the Medicare medication prices has tried to implement it for the first time since his first term. He signed a similar executive order in the last few weeks of his presidency, but a court regulation later blocked that the rule had come into force under the administration of President Joe Biden.
The pharmaceutical industry has argued that Trump’s attempt by Trump would give foreign governments the “upper hand” to decide the value of medication in the USA
It is likely that Trump’s Executive Order Monday only has the drugs that is covered by Medicare Part B, the insurance company for visits to the doctor. The beneficiaries of Medicare are responsible for capturing some of the costs for obtaining these medication during the doctor’s visits, and there is no annual upper limit for customary Medicare participants.
A report by the first Trump government showed that the United States spends twice as much as some other countries to cover these medication. Medicare part B The pharmaceutical expenditure exceeded 33 billion US dollars in 2021.
Trump has announced the announcement and explained that it will save taxpayers with great money.
“Our country is finally treated fairly, and the health costs of the citizens are reduced by numbers that have never been thought of before,” added Trump.
But many Americans will not see the savings.
Trump’s proposal would probably only affect certain medication that is covered by Medicare and administered in an office – think of infusions that treat cancer and other injectable games. But it could possibly bring billions of dollars of savings for the government – not necessarily the “trillion dollars” through which Trump was shaped in his post.
Medicare offers health insurance for around 70 million older Americans. Complaints about the US drug prices that are notoriously high, even compared to other huge and wealthy countries, have long since drawn the anger of both huge political parties, but a eternal solution has never released the congress.
More regular prescription drugs that are subject to a pharmacy are probably not covered by the modern order.
Trump’s contribution in the preview of the campaign officially came after he teased a “very big announcement” last week. He did not state any details, except not to notice that it was not associated with the trade or tariffs that he announced for a huge part of the world.
“We will make a very, very large announcement – as the big thing as possible,” said Trump last week.
He came into his first term in which he accused pharmaceutical companies “to get away with murder” and complained that other countries whose governments set the drug prices explained.
On Sunday, Trump again aimed at the industry and wrote that the “drug/pharmaceutical companies would say for years that it was research and development costs and that all these costs alone would be borne by the ‘Suckers’ of America.
With reference to the mighty lobby efforts by the drugstores, he said that campaign contributions can “do miracles, but not with me and not with the Republican party”.
“We’ll do the right thing,” he wrote.
